The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial.
 
Emilie Le Rhun
Honoraria - Bayer (I); Novocure (I); Pierre Fabre
Consulting or Advisory Role - Bayer; CureVac (I); Janssen; Leo Pharma; Medac (I); Novartis (I); Orbus Therapeutics (I); Philogen (I); Roche (I); Sandoz (I); Seagen
Research Funding - Bristol-Myers Squibb (Inst)
 
Thierry Gorlia
No Relationships to Disclose
 
Julia Furtner
Honoraria - Novartis; Seagen
Consulting or Advisory Role - Seagen
 
Joerg Felsberg
No Relationships to Disclose
 
Joost Jongen
No Relationships to Disclose
 
Claude-Alain Maurage
No Relationships to Disclose
 
Francois Ducray
Consulting or Advisory Role - Novocure
 
Patrick Roth
Honoraria - Merck; Novocure; Roche
Consulting or Advisory Role - Alexion Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Debiopharm Group; Midatech Pharma; MSD; QED Therapeutics
Research Funding - MSD (Inst); Novocure (Inst)
 
Peter Hau
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novocure
Speakers' Bureau - Lilly O.; Medac; Novocure; Seagen
Travel, Accommodations, Expenses - Medac; Novocure
 
Olivier L. Chinot
Honoraria - Abbvie
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Roche
 
Matthias Preusser
Honoraria - Abbvie; Adastra Pharmaceuticals; AstraZeneca; Bayer; BMJ Journals; Bristol-Myers Squibb; CMC Contrast; Daiichi Sankyo; Gan & Lee; Gerson Lehrman Group; GlaxoSmithKline; Lilly; Medahead; MedMedia; Merck Sharp & Dome; Mundipharma; Novartis; Roche; Sanofi; Tocagen
Consulting or Advisory Role - AbbVie; Bristol-Myers Squibb; CMC Contrast; Gerson Lehrman Group; GlaxoSmithKline; Mundipharma; Novartis; Roche
Research Funding - AbbVie (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Merck Sharp & Dohme; Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Mundipharma; Roche
 
Stephanie Cartalat
No Relationships to Disclose
 
Martin J. Van Den Bent
Employment - AstraZeneca (I)
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Boston Pharmaceuticals; carthera; chimerix; Genenta Science; Nerviano Medical Sciences
Research Funding - Abbvie (Inst)
 
Maike Collienne
Research Funding - Oncolytics (Inst)
 
Guido Reifenberger
No Relationships to Disclose
 
Michael Weller
Honoraria - Bayer; Novocure
Consulting or Advisory Role - Bayer (I); Curevac; Janssen (I); LEO Pharma (I); Medac; Novartis; Orbus Therapeutics; Philogen; Pierre Fabre (I); Roche; Sandoz; Seagen (I)
Research Funding - Quercegen Pharmaceuticals (Inst); Versameb (Inst)